Day, R.A. 1983. in: How To Write and Publish a Scientific Paper, Second Edition, ISI Press., Philadelphia, PA. pp. 15-19.* |
Masaki et al. 1981 Biochem. Biophys. Acta. 660, 51-55.* |
Gerhardt et al. 1981. in: Manual of Methods for General Bacteriology, Am. Soc. Microbiol., Washington D.C. pp. 156-157.* |
Enzyme Nomenclature, 1984 (Webb, D., et al.) Academic Press., Orlando, pp. 270-533.* |
Gray et al., 1982. Nature. 295, 593-598.* |
Buell et al., 1985. Nuc. Acids Res. 13, 1923-1938.* |
Watson, J.D. 1987. in: Molecular Biology of the Gene. 3rd Edition. Benjamin/Cummings Publ. Co. Inc. CA. p. 313.* |
Saito et al., 1987. J. Biochem. 102, 111-122.* |
Stryer, L. 1975. in: Biochemistry. W H Freeman & Co. San Francisco. p. 636.* |
Maruyama et al. 1986 Nuc. Acids Res. Supplement. 14, r151-R197.* |
Weinstock et al. 1983. Proc. Natl. Acad. Sci. USA 80, 4432-4436.* |
Gramtham et al. 1981 Nuc. Acids Res. 9, r43-r74.* |
Mikuni et al. 1985, Siekagaku 57, 854. English translation relied upon.* |
Hase et al. 1984, FEBS Letters 166, 39-43.* |
Isemura et al. 1984, J. Biochem. 96, 489-498.* |
Yoshida et al. 1984, FEBS Letters 170, 135-138.* |
Allen et al. 1985, J. Cell Sci. Suppl. 3, 29-38.* |
Houmard et al. 1972, Proc. Natl. Acad. Sci. USA 69, 3506-3509.* |
Takamatsu et al. 1984, 7th Annual Meeting of Molecular Biology Society of Japan, (Dec. 4-7) p. 45, abstract No. B72, English translation relied upon.* |
Communication of a Notice of Opposition in European Patent 0 206 769 B1, May 18, 1993. |
Letter of Opposition of EP-B1 0 206 769, May 12, 1993. |
S. Oikawa et al, Nature, vol. 309, pp. 724-726, (1984). |
B. Greenberg et al, Nature, vol. 312, pp. 656-658 (1984). |
M. Nemer et al, Nature, vol. 312, pp. 654-656 (1984). |
K. Maeda et al, Biochimica et Biophysica Acta, vol. 828, pp. 222-228 (1985). |
T. Miyata et al, The Journal of Biological Chemistry, vol. 259, pp. 8924-8933 (1984). |
Reply Brief of Patentee in Japanese Patent Application 61-141900, Jul. 29, 1991. |
Partial Translation of Reply Brief of Patentee Filed Jul. 29, 1991 for Japanese Patent Application No. 61-141900. |
Patentees Reply to Opposition in European Patent No. 0 206-769 Fujisawa Pharmaceutical Co., Ltd.—Opposition by Suntory Limited, pp. 1-8, Dec. 16, 1993 (With Appendix I). |
Brief Communication in European Patent No. 0 206 769, Jul. 11, 1994. |
Opponents Observations in Response to the Observations of the Patentee, Opposition to EP-B1 0 206 769, Jul. 1, 1994. |
Translation of Reply Brief of Patentee Filed Jul. 29, 1992, Opposition to Japanese Patent Application 61-141900. |
F. Marston, Biochem. J., vol. 240, pp. 1-12 (1986). |
Translation of Seikagaku, vol. 57, Published Aug. 25, 1985, “2B-p1 Isolation of Recombinant Human Cardionatrin from E. Coli” S. Kanaya et al. |
Experimental Report, Purpose: To Determine Whether α-hANP can be Liberated from a Chimeric Protein Comprising a Protective Peptide and αhANP Linked Through Glu By V8 Protease, pp. 1-9, Filed by Suntory in Opposition to European Patent No. 0 206 769 filed Jul. 1, 1994. |
Decision of the Technical Board of Appeal 3.3.1 of Feb. 14, 1989 in Opposition to European Patent Application 83 870 003.7. |
Letter from Dr. Hans-Rainer Jaenichen is Opposition to European Patent No. 0 206 769, Jul. 21, 1994. |
Petition in Opposition to European Patent No. 0 206 769, Jul. 21, 1994. |
P. Seeburg et al, Nature, vol. 276, pp. 795-798 (1978). |
D. Goeddel et al, Nature, vol. 281, pp. 544-548 (1979). |
D. Goeddel et al, Proc. Natl. Acad. Sci. USA, vol. 76, pp. 106-110 (1979). |
K. Itakura et al, Science, vol. 198, pp. 1056-1063 (1977). |
M. Courtney et al, Proc. Natl. Acad. Sci. USA, vol. 81, pp. 669-673 (1984). |
Revocation of European Patent No. 0 206 769 Under Art. 102(1) or Art. 102(3) EPC, Jan. 23, 1995. |
Provision of a Copy of the Minutes in European Patent No. 0 206 769 Under Rule 76(4) EPC, Jan. 23, 1995. |
Statement of the Grounds of Appeal (Case No. T0202/95-334) in Opposition to European Patent No. 0 206 769, May 22, 1995. |
Patentees' Further Submissions in Opposition to European Patent No. 0 206 769, Jan. 4, 1995. |
Response to Opposition in Opposition to Japanese Patent Application 61-141900, Mar. 11, 1994. |
T. Yonezu et al, FEBS Letters, vol., 203, pp. 149-152 (1986). |
Methods in Enzymology, “Proteolytic Enzymes: Serine and Cysteine Peptidases”, vol. 244, pp. 126-137, Ed. A. Barrett (1994). |
Letter by Robert J. Gaunt in Opposition to European Patent No. 0 206 769, Jan. 3, 1997. |
Nikkei Biotech, p. 3, Apr. 24, 1989, with Certified English Language Translation. |
Nikkei Biotech, p. 3, Mar. 27, 1995, with Certified English Language Translation. |
Nikkei Biotech, p. 3, Sep. 9, 1985, with Certified English Language Translation. |
S. Tanaka et al, Tanppakushitsu, Kakusan, Koso, vol. 35, pp. 2613-2619 (1990) with English Language Translation. |
J. Knott et al, Eur. J. Biochem., vol. 174, pp. 405-410 (1988). |
PG 45 of the Program and Abstract of the 7th Annual Meeting of Molecular Biology Society of Japan, Dec. 4-7, 1984 with English Language Translation. |
Isolation and Purification of α-Human Atrial Natriuretic Polypeptide (α-hANP), pp. 1-2, Feb. 9, 1996. Yoshimasa Saito. |
Isolation and Purification of α-Human Atrial Natriuretic Polypeptide (α-hAMP), pp. 1-2. |
Decision, Case No. T 0292/85, Date of Decision: Jan. 27, 1988. |
Decision, Case No. T 0293/85, Date of Decision: Jan. 27, 1988. |
Letter of the Opponent Opposition to European Patent No. 0 206 769, Oct. 16, 1995. |
Enzyme Nomenclature, Academic Press, New York, pp. 388-389 and 398-399, (1992). |
Eur. J. Biochem, “The Isolation and Characterisation of Human Atrial Natriuretic Factor Produced as a Fusion Protein in Escherichia Coli”, vol. 174, pp. 405-410, (1988). |
C.W. Dykes et al, Eur. J. Biochem., “Expression of Atrial Natriuretic Factor as a Cleavable Fusion Protein with Chloramphenicol Acetyltransferase in Esherichi Coli”, vol. 174, pp. 411-416, (1988). |
Tanpakushitsu, Kakusan, Koso, vo. 35, pp. 2613-2619, (1990) (with English Translation). |